Global Self-Monitoring Blood Glucose Device Market Size and Share Analysis - Growth Trends and Forecast Report 2025-2033

Self-Monitoring Blood Glucose Device Market Outlooks

Self-Monitoring Blood Glucose (SMBG) devices are medical equipment used for testing and monitoring blood glucose levels, mainly applied by diabetes patients. SMBG devices enable patients to test their blood glucose levels easily at home, facilitating real-time condition monitoring. A glucose meter, test strips, and lancet are normally included in an SMBG device to draw a tiny blood sample, typically from a finger.

The main function of SMBG devices is to assist people with diabetes in controlling their condition by monitoring glucose levels during the day. Such information is essential for making medication, insulin dosage, diet, and exercise adjustments. SMBG devices are also useful to detect hypoglycemia (low blood sugar) or hyperglycemia (high blood sugar) and prompt users to take appropriate action in order to avoid complications. Healthcare professionals use SMBG data to determine the effectiveness of treatment and make appropriate changes to a patient's care plan. The devices play an important role in enabling patients to have greater control of their health.

Growth Drivers for Self-Monitoring Blood Glucose Devices

Growing Prevalence of Diabetes

Global diabetes, especially Type 2 diabetes, prevalence is one of the biggest growth drivers of the SMBG device market. Sedentary life, obesity, and unhealthy eating habits have all contributed to the rising diabetes burden, mandating regular blood glucose monitoring. SMBG equipment enables patients to take control of their condition, decreasing complications and enhancing quality of life. This is backed by increasing education on the value of self-monitoring for diabetes control. Currently, 537 million adults between the ages of 20 to 79 are living with diabetes, which is about 1 in 10 individuals. The number is anticipated to rise by 643 million by 2030 and it is anticipated to be at 783 million by 2045. In 2022, 14% of adults aged 18 and above had diabetes, a rise of 7% in 1990. Specifically, over half (over 59% (59%) over 59% (59%) over 30 years of age who have diabetes were not using drugs for their condition in 2022.

Advances in SMBG Technology

Technological innovations, including smaller devices, smartphone connectivity, and real-time monitoring capabilities, have improved the ease of use and precision of SMBG devices. Innovations such as Bluetooth devices and cloud-based data transfer enable patients and healthcare professionals to monitor glucose trends and personalize treatment regimens. These advancements are boosting the use of SMBG devices across different populations, fueling market growth. Abbott launched a new system for continuous monitoring of glucose and ketones with an innovative design bio-wearable in June 2022.

Increasing Awareness and Government Support

Governments and healthcare providers globally support campaigns for early diabetes detection and care. Subsidized healthcare and reimbursement policies offer SMBG devices at affordable costs. Educational campaigns emphasizing the advantages of frequent glucose monitoring have inspired patients and caregivers to embrace SMBG devices, substantially driving market growth. During December 2023, Roche Diabetes Care has initiated initiatives in India that include diabetes awareness, education, and screening. These programs intend to educate and screen people for diabetes.

Self-Monitoring Blood Glucose Device Market Challenges

High Cost of Devices and Consumables

The price of SMBG devices and ongoing costs for test strips and lancets are a major challenge, particularly in low-income areas. Frequent testing is unaffordable for many patients, which restricts market penetration. Although cost-saving solutions are being brought to the market, affordability is still a constraint to mass adoption.

Accuracy and User Compliance Issues

Reliable glucose values are contingent upon correct use of SMBG devices, but user mistakes in calibration, testing methods, or infrequent monitoring undermine results. Insufficient training and knowledge amplify such problems, which result in inconsistent glucose control. Such a problem taints the utility of SMBG devices in enhancing the course of diabetes.

Test Strips Self-Monitoring Blood Glucose Device Market

Test strips are a key element of SMBG devices that are employed in order to measure glucose content in blood samples. Due to their frequent use, they are a major revenue-generating component of the SMBG market. Advances in test strip design have made them more accurate and user-friendly. Yet, the repeated expense of test strips continues to be a concern, prompting manufacturers to provide low-cost alternatives.

Lancets Self-Monitoring Blood Glucose Device Market

Lancets, for finger-prick blood draws, are central to the SMBG process. The lancet market is aided by technologies that reduce pain and enhance safety, including ultra-thin needles and retractable technologies. Even though they are disposable, cost and patient discomfort continue to be impediments to regular use, offering opportunities for additional product improvements.

Type 2 Diabetes Self-Monitoring Blood Glucose Device Market

The Type 2 diabetes segment leads the SMBG market because of the requirement for frequent glucose monitoring in patients. SMBG devices assist Type 2 diabetes patients in controlling glycemia and avoiding complications. Home-based monitoring convenience and growing awareness of its advantages fuel demand for SMBG devices in this segment. Global prevalence of diabetes stands at 6.1%, which is one of the major causes of death and disability. North Africa and the Middle East record the highest rate of 9.3% and are estimated to grow to 16.8% in 2050, with Latin America and the Caribbean expected to increase to 11.3%.

Hospitals Self-Monitoring Blood Glucose Device Market

Hospitals are major consumers of SMBG devices for diabetes management, especially in inpatient and initial diagnosis settings. The devices play a vital role in glucose monitoring during treatment and educating patients with new diabetes diagnoses. Hospitals also prescribe SMBG devices for home use, which enhances the growth of the market. The growing prevalence of diabetes further increases the use of SMBG devices in healthcare.

United States Self-Monitoring Blood Glucose Device Market

The United States dominates the market for SMBG devices because it has a high rate of diabetes, well-established healthcare infrastructure, and technological development. Government measures encouraging diabetes management and insurance plans covering SMBG devices increase availability. Moreover, major market contributors and the adoption of sophisticated technologies such as ongoing data sharing benefit the growth of the market. August 2022, Abbott collaborated with WW International Inc. to bring together WW's weight management program for diabetes with Abbott's FreeStyle Libre offerings, to empower individuals with diabetes to better manage their condition.

Germany Self-Monitoring Blood Glucose Device Market

Germany's robust healthcare system and focus on medical innovation fuel its SMBG device market. Growing incidence of diabetes and education regarding self-monitoring are factors driving the demand. The government's emphasis on preventive care and insurance coverage for SMBG devices guarantee their mass adoption, thus making Germany the driving force in the European market. The German Diabetes Centre (DDZ) puts the number of Germans suffering from diabetes at 8.5 million, with Type 2 diabetes cases projected to reach twelve million by 2040. In February 2024, Dexcom launched the Dexcom ONE+, a real-time continuous glucose monitor that enables patients to wear the sensor in three locations on the body for easier monitoring of blood sugar levels.

India Self-Monitoring Blood Glucose Device Market

India's SMBG device market is expanding at a fast pace as a result of the rising prevalence of diabetes and growing awareness regarding its management. Urbanization, lifestyle changes, and food patterns have fueled the burden of diabetes, which has made regular monitoring necessary. Launch of low-cost SMBG devices specifically designed for the Indian market is also enhancing adoption levels. July 2024: Fitterfly collaborated with Ascensia Diabetes Care to offer the Bluetooth-capable Contour Plus Elite glucometer within its diabetes program kits and mobile app for more effective management of diabetes in its program members.

Brazil Self-Monitoring Blood Glucose Device Market

The SMBG device market in Brazil is growing based on increasing instances of diabetes as well as expenditure on healthcare. Government policies and campaigns related to awareness about diabetes have enhanced availability of SMBG devices. Collaborations between manufacturers and healthcare providers propel the market to launch cost-effective and innovative devices. January 2023: LifeScan made a statement that the Journal of Diabetes Science and Technology published a study titled Improved Glycemic Control Using a Bluetooth Connected Blood Glucose Meter and Mobile Diabetes App. The study compared data from more than 144,000 individuals with diabetes, making it one of the largest combined datasets for mobile apps and blood glucose meters.

UAE Self-Monitoring Blood Glucose Device Market

The UAE SMBG device market is expanding with increasing diabetes rates and growing healthcare expenditures. Adoption is fueled by government-initiated campaigns to raise awareness and promote preventive healthcare. Development of sophisticated healthcare infrastructure and the launch of advanced SMBG technologies also contribute to the growth of the market in the country. Feb 2023, EOFlow Co., Ltd. announced that its partner in the Gulf, GulfDrug LLC, made available the tubeless, wearable, and disposable insulin pump "EOPatch" in the UAE. Users can control insulin infusions through the Narsha app on Android and iOS phones from February 2023.

Self-Monitoring Blood Glucose Device Market Segments

Product

1. Test Strips
2. Lancets
3. Blood Glucose Meters

Application

1. Type 1 Diabetes
2. Type 2 Diabetes
3. Gestational Diabetes

End User

1. Hospital Pharmacies
2. Retail Pharmacies
3. Online Sales
4. Diabetes Clinics & Centers

Countries

North America

• United States
• Canada

Europe

• France
• Germany
• Italy
• Spain
• United Kingdom
• Belgium
• Netherlands
• Turkey

Asia Pacific

• China
• Japan
• India
• Australia
• South Korea
• Thailand
• Malaysia
• Indonesia
• New Zealand

Latin America

• Brazil
• Mexico
• Argentina

Middle East & Africa

• South Africa
• Saudi Arabia
• UAE

All the Key players have been covered from 5 Viewpoints:

• Overview
• Key Person
• Product Analysis
• Recent Development
• Revenue

Key Players Analysis

1. Abbott Laboratories
2. Medtronic
3. Dexcom, Inc.
4. B. Braun Melsungen AG
5. DarioHealth Corp
6. Sanofi
7. Bionime Corporation
8. Novo Nordisk

Report Details: